SGFCX
Price
$42.39
Change
+$0.39 (+0.93%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

SGFCX vs VIGIX

Header iconSGFCX vs VIGIX Comparison
Open Charts SGFCX vs VIGIXBanner chart's image
Sparrow Growth C
Price$42.39
Change+$0.39 (+0.93%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
SGFCX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SGFCX vs. VIGIX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGFCX is a Buy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. SGFCX (62.9M). VIGIX pays higher dividends than SGFCX: VIGIX (0.53) vs SGFCX (0.00). SGFCX was incepted earlier than VIGIX: SGFCX (13 years) vs VIGIX (27 years). SGFCX is a more actively managed with annual turnover of: 55.79 vs. VIGIX (5.00). SGFCX has a lower initial minimum investment than VIGIX: SGFCX (1000) vs VIGIX (5000000). SGFCX annual gain was more profitable for investors over the last year : 36.30 vs. VIGIX (34.37). VIGIX return over 5 years is better than : 129.76 vs. SGFCX (72.25).
SGFCXVIGIXSGFCX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years27 years-
Gain YTD35.77834.272104%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets62.9M282B0%
Annual Yield % from dividends0.000.53-
Returns for 1 year36.3034.37106%
Returns for 3 years1.0532.773%
Returns for 5 years72.25129.7656%
Returns for 10 years136.95298.5846%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology